Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.23 +0.13 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Atara Biotherapeutics (ATRA) Acquisitions (2026)

Updated

Analysis

Atara Biotherapeutics (ATRA) Acquisitions (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -17.15 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.59 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Atara Biotherapeutics 124.14 Mn 114.24 Mn 959,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -746,000.00
API Access

Atara Biotherapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=ATRA&period=max&api_key=YOUR_API_KEY